Biomea Fusion, Inc. (BMEA) FinancialsBMEABiomea Fusion, Inc.

Evaluating the bottom line, Biomea Fusion, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -164.14%, provide a clear picture of how effectively BMEA converts its operational activities into shareholder value.

In the context of the broader market, BMEA competes directly with industry leaders such as AARD and CPIX. With a market capitalization of $125.40M, it holds a significant position in the sector. When comparing efficiency, BMEA's gross margin of N/A stands against AARD's N/A and CPIX's 100.00%. Such benchmarking helps identify whether Biomea Fusion, Inc. is trading at a premium or discount relative to its financial performance.

Biomea Fusion has shown an improving trend in its financial performance, with a narrowed net loss of $8.33 million in Q2 2026 compared to $20.74 million in the same quarter last year, indicating effective cost management and operational improvements.